Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Cost-effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in the United States.
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cost-effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in the United States.
Cost-effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in the United States. Clin Infect Dis. 2019 11 13; 69(11):1888-1895.
View in:
PubMed
subject areas
Antiviral Agents
Cost-Benefit Analysis
Female
Hepacivirus
Hepatitis C, Chronic
Humans
Pregnancy
Quality-Adjusted Life Years
United States
authors with profiles
Nancy Reau